For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

We enhance care, provide support and strive to eliminate Alzheimer's disease through the advancement of research in our state-of-the-art laboratories.

Our Mission

News

The Eighth Annual Appel Alzheimer's Disease Research Institute Symposium is scheduled virtually on Wednesday, October 14th, 2020

The Eighth Annual Appel Alzheimer's Disease Research Institute Symposium is scheduled virtually on Wednesday, October 14th, 2020 from 1:00PM - 2:30PM.This is an outstanding annual event hosted by...

Congratulations! Second R01 from the NIH Awarded to Dr. Anna Orr’s team

Mitochondria are organelles that produce energy and participate in normal intracellular signaling. However, they also release free radicals that can impair neural cells and promote disorders of the...

Congratulations! New R01 from NIH awarded to Dr. Wenjie Luo

DAP12 (also called TYROBP) acts as an adaptor protein in microglia involved in the cross-interaction of signaling networks of microglial surface immune receptors, including AD risk gene TREM2. DAP12...

Events

Appel Institute Forum on Neurodegeneration

January 27, 2021 - 12:00pm

"Why haven't we cured Alzheimer's disease yet? The complexity of us and the disease"

Appel Institute Forum on Neurodegeneration

January 27, 2021 - 12:00pm
"Why haven't we cured Alzheimer's disease yet? The complexity of us and the disease"

BMRI Work in Progress Seminar Series

February 5, 2021 - 12:00pm
“Alzheimer’s peptides -amyloid and tau undermine neurovascular regulation” Laibaik Park, PhD, Associate Professor of Research in Neuroscience, BMRI, WCM

Appel Alzheimer's Disease Research Institute | Click Here